Okay, so that's a great point right there. So on that side of it, on the medical side, about the actual. The question asking the patient during delivery about that, the consent to take your tissue for research. Yeah, there's, there's a lot of, there's a lot of points to that. I'm more so of taking the tissue for the reasoning of the mesocoma stem cells or the gelatinous material outside when you're outside of the tissue. I mean, let's, let's go for the umbilical cord. The umbilical cord is the connection between the, you know, the fetus, the baby and the mother. Right. And it delivers all the nutrients through there. Well, outside is what we're trying to achieve. That, that mesocoma stem cell, the gelatinous material called Wharton's jelly, that has the highest concentration and it's not pretty much compromised by any type of like, like pathogen that's delivered from the mother to the baby. So that's really important. But when you think about the problems that we're having in the industry, it's not really regulated by the fda. The FDA just kind of regulates the lab and not so much the clinical side of it, because the clinical side of it is a broad stroke saying that from the FDA that this is experimental or research. That's why you have to sign more consent forms and a probably a report that says that you're in this research and you're allowed to do this type of therapy. Other than that, it's not regulated. But then going to the donor site, we're starting to run out of these donors. Right. Donors are basically volunteers from a C section delivery. Say, would you like to give this tissue? And then you're starting to see less a list because you have to vet these people. They have to be pretty much drug free. They have to have no pathogens, meaning no diseases, STDs and all that stuff. And there's a whole battery of tests, you know, just like any type of examination go through. There's a questionnaire, blood work, serology, all that stuff. And then when they clear, then we take their tissue in exchange. They would get a discount for their banking of their cord if they want to do that for their child. So it's like a win win in that world. But we're starting to lose those donors. They're starting to slow down and the supply is not there to where the unethical side comes in is that you're going to start hearing all these labs pop up, these labs saying, hey, it's a lot cheaper, it's easier, you know, and then you like think like, well, how is it cheaper? Well, this is where the FDA is starting to come down on these guys because it's not real tissue. It's either from maybe not really from the umbilical cord portion of what they call the Wharton's jelly or the placenta, that gelatinous material, but it's coming from other tissue, like maybe vaginal tissue. Sometimes there's cases you hear about coming from bovine or animal or some pig. So you're starting to hear that come out now on our end, you know, as a clinician, we don't really see and know what's going on because, you know, we don't have to that vetting process of a lab and trying to analyze what we're getting from the actual lab. So that's where the confusion is. So that's why it's very important to find out exactly who is your source, who is that? And there should be a process. Every, you know, clinic should have a type of form that you can follow and what's called traceability forms. You can follow this form all the way back to the donor and the donor will have its questions, the blood work and all that stuff. So it's, yeah, there's a big confusion out there about, you know, where to get it, how to do it, how's it match. And the most important thing, going back to one more thing about a risk factor about these live cells that people like promote. Live cells are neat. It's interesting, but you have to understand that live cell has a DNA. The DNA is dangerous. When you put it into your body, it's going to turn into something. So if you're going after your tendon and that DNA is meant to be like a, like a heart tissue, well, it's going to grow in that area. So you got to be careful. Now you're in a tumor formation, so that's a caution.
